ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Lung Cancer Studies Described by DCT, VA

May 9, 1975

Funding Opportunities.

May 10, 2002

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

In Brief DCCP Directorship Draws 100 Names; Upon Agrees Centers Programs Needs More Staff

January 13, 1978